Business Wire

Synchron’s Stentrode Brain-Computer Interface Receives Breakthrough Device Designation from FDA

Stentrode is the only implantable brain-computer interface that does not require open brain surgery and is currently in clinical trials SAN FRANCISCO & NEW YORK & MELBOURNE, Australia--(BUSINESS WIRE) ...
Business Wire

Synchron Announces Long-Term Safety Results from Fully Implanted Endovascular Brain-Computer Interface Stentrode ™ for Severe Paralysis

NEW YORK--(BUSINESS WIRE)--Synchron, a brain computer interface (BCI) company, today announced the results from a study in which four people with ALS received an implant of Synchron’s Stentrode™ ...
TechJuice

Brain Chip Startups Expand Trials as Global Competition Grows

Brain chip technology advances rapidly as startups expand trials, raising ethical, safety, and privacy concerns worldwide.
BioWorld

Synchron raises $200M to accelerate Stentrode BCI platform

Synchron Inc.'s recent $2 million raise for its Stentrode brain-computer interface platform comes at a pivotal time for the technology. Advances in BCI development, ongoing clinical trials and growing ...
Fast Company

Apple teams up with a brain-computer startup to turn thoughts into device control

Apple is collaborating with brain-computer interface company Synchron to develop technology that lets users control devices using neural signals. “This marks a defining moment for human-device ...